|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||306.40 - 310.80|
|52-week range||196.00 - 321.40|
|Beta (5Y monthly)||0.42|
|PE ratio (TTM)||48.71|
|Earnings date||12 Feb 2021|
|Forward dividend & yield||4.00 (1.30%)|
|Ex-dividend date||27 Apr 2021|
|1y target est||205.31|
Société anonyme au capital de 111 974 316 eurosSiège social : 14, rue Royale, 75008 Paris632 012 100 R.C.S. ParisLegal Entity Identifyer : 529900JI1GG6F7RKVI53 Disclosure of total number of voting rights and number of sharesin the capital at 28 February 2021 Pursuant to article L-233-8 II of the French “Code de Commerce” and 223-16 of the AMF's General Regulations: Total number of shares 559,872,400 Number of real voting rights (excluding treasury shares) 559,872,400 Theoretical number of voting rights 559,872,400 (including treasury shares*) (*) pursuant to article 223-11 of the AMF’s General Regulations About L'Oréal L’Oréal has devoted itself to beauty for over 110 years. With its unique international portfolio of 36 diverse and complementary brands, the Group generated sales amounting to 29.9 billion euros in 2019 and employs 88,000 people worldwide. As the world’s leading beauty company, L’Oréal is present across all distribution networks: mass market, department stores, pharmacies and drugstores, hair salons, travel retail, branded retail and e-commerce.Research and innovation, and a dedicated research team of 4,000 people, are at the core of L’Oréal’s strategy, working to meet beauty aspirations all over the world. L’Oréal’s sustainability commitment for 2020 “Sharing Beauty With All” sets out ambitious sustainable development objectives across the Group’s value chain. www.loreal.com CONTACTS AT L'ORÉAL Individual shareholders and market authoritiesMr. Christian MUNICHPhone: +33.(0)firstname.lastname@example.org Financial analysts and institutional investorsMrs. Françoise LAUVINPhone: +33.(0)email@example.com For more information, please contact your bank, broker or financial institution (I.S.I.N. code: FR0000120321), and consult your usual newspapers, the Internet site for shareholders and investors, www.loreal-finance.com or the L’Oréal Finance app, alternatively, call +33 1 40 14 80 50."This document does not constitute an offer to sell, or a solicitation of an offer to buy, L’Oréal shares. If you wish to obtain more comprehensive information about L’Oréal, please refer to the public documents registered in France with the Autorités des Marchés Financiers [which are also available in English on our Internet site: www.loreal-finance.com].This document may contain some forward-looking statements. Although the Company considers that these statements are based on reasonable hypotheses at the date of publication of this release, they are by their nature subject to risks and uncertainties which could cause actual results to differ materiallyf rom those indicated or projected in these statements." Attachment Declaration at February 28 2021
Maybelline and Lancome maker L'Oreal aims to derive nearly all its ingredients from renewable plant sources and abundant minerals by 2030, it said on Thursday, as demand for organic and environmentally-friendly cosmetics grows. That poses a major challenge in terms of adapting packaging, but also developing products that can be preserved and deliver similar results to non-natural ones. L'Oreal said over the next 10 years, 95% of the ingredients across all its brands and ranges would come from plants and flowers that can renewed or replanted, and minerals that can be found in abundance, up from around 70% now.
L'Oreal, the world's biggest cosmetics group, forecast a strong rebound in makeup sales when the COVID-19 pandemic gives way to a "roaring 20s" when people get dressed up and go out again to socialise. Shares in L'Oreal, owner of brands such as Maybelline, Lancome and Garnier, rose on Friday after the group reported higher than expected fourth-quarter sales growth, broadly outperforming a cosmetics market hit hard by the pandemic. L'Oreal CEO and Chairman Jean-Paul Agon said sales would accelerate sharply as COVID-19 vaccines are distributed and levels of infection subside.